SCHEMBL8790711

SCHEMBL8790711

CC1(c2ccccc2N=Cc2c(Cl)cccc2Cl)OCCO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 2/20 0.40
CYP1A2 P05177 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
LMNA P02545 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
BLM P54132 1/20 0.34
HIF1A Q16665 1/20 0.34
HPGD P15428 1/20 0.34
TAAR1 Q96RJ0 2/20 0.33
MAOA P21397 2/20 0.33
SLC22A1 O15245 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
CHRM1 P11229 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
DRD1 P21728 1/20 0.33
TBXA2R P21731 1/20 0.33
SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790706 1.00 PBRM1 (0.40) PBRM1CYP1A2NPSR1LMNACYP2D6
SCHEMBL8005653 0.75 TAAR1 (0.45) LMNATSHRTAAR1SLC6A4OPRM1
SCHEMBL11409371 0.73 HPGD (0.53) PBRM1CYP1A2NPSR1LMNACYP2D6
SCHEMBL11409362 0.73 HPGD (0.53) PBRM1CYP1A2NPSR1LMNACYP2D6
SCHEMBL31747107 0.66 TDP2 (0.31)
SCHEMBL11409456 0.65 HPGD (0.49) PBRM1CYP1A2LMNAHPGDTAAR1
SCHEMBL11409452 0.65 HPGD (0.49) PBRM1CYP1A2LMNAHPGDTAAR1
SCHEMBL11403068 0.63 MAOA (0.46) PBRM1CYP1A2NPSR1LMNACYP2D6
SCHEMBL11403066 0.63 MAOA (0.46) PBRM1CYP1A2NPSR1LMNACYP2D6
SCHEMBL12681587 0.63 TSHR (0.38) TSHROPRM1SMN1; SMN2HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0620809-B1 $g(a)-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 1997-03-05 EP disclosed
US-5480912-A Method of treating HIV-1 with α-substituted benzenemethanamine derivatives JANSSEN PHARMACEUTICA, N.V. (BE) 1996-01-02 US disclosed
US-5407961-A Useful for treating HIV-1 virus JANSSEN PHARMACEUTICA N.V. (BE) 1995-04-18 US disclosed
EP-0620809-A1 -g(a)-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES. JANSSEN PHARMACEUTICA NV (BE) 1994-10-26 EP disclosed
WO-1993013052-A1 α-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1993-07-08 WO disclosed